Not to mention the worth of their patented IP.............depending on the product, the market assess these biotech stock IP (especially patented) very high, it alone could be worth it's current market capital if it becomes FDA approved.
RAP charting, page-8420
Currently unlisted. Proposed listing date: 4 SEPTEMBER 2024 #
-
- There are more pages in this discussion • 6 more messages in this thread...
You’re viewing a single post only. To view the entire thread just sign in or Join Now (FREE)